2015 Fiscal Year Final Research Report
Elucidating the molecular mechanism of a peptide, SCRG1, derived from mesenchymal stem cells to suppress the osteoclast differentiation.
Project/Area Number |
25463224
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Periodontology
|
Research Institution | Iwate Medical University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
Chosa Naoyuki 岩手医科大学, 歯学部, 講師 (80326694)
|
Co-Investigator(Renkei-kenkyūsha) |
Ishisaki Akira 岩手医科大学, 歯学部, 教授 (20356439)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Keywords | 歯周組織再生 / 炎症抑制 / 炎症性サイトカイン / 炎症性骨吸収 / 間葉系幹細胞 |
Outline of Final Research Achievements |
Mesenchymal stem cells (MSCs) retain the ability to self-renew and differentiate into mesenchymal cells. Therefore, MSCs are strong candidates for use in regenerative medicine and cell therapy. Bone marrow-derived MSCs migrated to various tissues including periodontal tissue by chemotaxis, which plays important roles in anti-inflammatory response and tissue repair. We demonstrated that stimulation of inflammatory cytokines, IL-1β, IL-6 and TNF-α, to increase the production and secretion of SDF-1 and MCP-1 in periodontal ligament-derived MSC-like cells. Interestingly, these chemokines specifically increased the migration of bone marrow-derived MSCs, but did not increase that of the periodontal ligament-derived MSC-like cells. In summary, our studies suggested that efficient regenerative medicine could be implemented by effective use of distinct MSCs obtained from various tissues.
|
Free Research Field |
口腔生化学
|